Join Jillian Manus, Managing Partner at Structure Capital for an exciting discussion on the future of digital health with Guillaume de Zwirek, Founder of WELL and Dr. Carlos Bustamante, Founding Director of the Stanford Center for Computational, Evolutionary, and Human Genomics (CEHG) and Inaugural Chair of the Department of Biomedical Data Science.
If 2017 was a record-shattering year for digital health, what will 2018 and beyond bring?
Last year, we saw investments in digital health reach $7 billion with the most mega deals ever ($100M or more). It was also the year the FDA approved the “digital pill,” hospitals experimented with VR for pain management, and insurance companies officially integrated fitness wearables into wellness programs.
Today, healthcare is in a state of disruption and opportunities for change are abundant. There are also real challenges. With escalating healthcare costs, overburdened hospitals, and an aging population facing chronic conditions, this session will explore how technology can provide sustainable solutions for both patients and providers. Jillian identifies key trends and evaluates their impact for the future. And she’ll explore new systems of support along with critical challenges founders and investors face as they strive to improve healthcare for all.
Jillian Manus is an experienced banking and media executive, a technology investor and entrepreneur. She is the Managing Partner of Structure Capital, a Silicon Valley-based venture capital firm that invests in early-stage technology companies.
As a frequent global public speaker, Jillian provides business and political commentary at events and in the media, primarily for Bloomberg, Fox News and CNBC’s Squawk Box. Currently she serves as a co-host on the podcast The Pitch, which has been called “a better, more realistic version of Shark Tank.” She was also named one of the Most Influential Women in Bay Area Business 2016 by the San Francisco Business
Guillaume de Zwirek is the Founder and CEO of WELL, a modern healthcare communication platform offering one place to manage all interactions between staff and patients. WELL customers enjoy increased staff efficiencies, reductions in no show rates and phone calls, and improved customer satisfaction. Previously, Guillaume was the Director of Publishing & Performance Marketing at Graphiq.com where he founded its publishing business and grew it to over four million monthly readers. He started his career as a Product Marketing Manager at Google where he was responsible for major initiatives for Search and Google Trends. Guillaume is a classical guitarist and 6x Ironman triathlete.
Dr. Carlos Bustamante, Founding Director of the Stanford Center for Computational, Evolutionary, and Human Genomics (CEHG) and Inaugural Chair of the Department of Biomedical Data Science.
Dr. Carlos D. Bustamante is an internationally recognized leader in the application of data science and genomics technology to problems in medicine, agriculture, and biology. He received his Ph.D. in Biology and MS in Statistics from Harvard University (2001), was on the faculty at Cornell University (2002-9), and was named a MacArthur Fellow in 2010. He is currently Professor of Biomedical Data Science, Genetics, and (by courtesy) Biology at Stanford University. Dr. Bustamante has a passion for building new academic units, non-profits, and companies to solve pressing scientific challenges. He is Founding Director of the Stanford Center for Computational, Evolutionary, and Human Genomics (CEHG) and Inaugural Chair of the Department of Biomedical Data Science. He is the Owner and President of CDB Consulting, LTD. and also a Director at Eden Roc Biotech, founder of Arc-Bio (formerly IdentifyGenomics and BigData Bio), and an SAB member of Embark Veterinary, the Mars/IBM Food Safety Board, and Digital Ventures.